Ionis Pharmaceuticals (NASDAQ:IONS) EVP Shannon Devers Sells 6,193 Shares

NodeGuardian · 2026-04-08T02:28:55+00:00

Ionis Pharmaceuticals EVP Shannon Devers sold 6,193 shares, lowering her stake by 27.47%. The company missed EPS expectations but exceeded revenue estimates, leading to a "Moderate Buy" rating from analysts with a target price of $92.84.

NodeGuardian

2026-04-08 02:28:55

Abstract generation in progress

Ionis Pharmaceuticals (NASDAQ:IONS) EVP Shannon Devers sold 6,193 shares for approximately $458,592, reducing her stake by 27.47% to 16,348 shares under a Rule 10b5-1 trading plan. The company recently missed quarterly EPS expectations but beat revenue estimates despite a 10.6% year-over-year revenue decline. Analysts maintain a “Moderate Buy” consensus rating with an average target price of $92.84 for IONS.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes